Atlas Trials

Donghua Zhang

7 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Donghua Zhang

RecordFirmDate
Clinical Study on the Safety and Efficacy of CD7-Targeted Chimeric Antigen Receptor (CAR) Gene-Modified T Cells for the Treatment of CD7-Positive Hematological Malignancies (NCT07345780)Donghua Zhang2026-12-31
A Clinical Study Evaluating the Safety and Efficacy of BCMA-GPRC5D CAR-T in Patients With Relapsed/Refractory Multiple Myeloma Who Have Received Three or More Lines of Treatment (NCT07376720)Donghua Zhang2026-02-15
Safety and Efficacy of CLL1 CAR-T Followed by Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia (NCT07342244)Donghua Zhang2026-01-30
Clinical Study Evaluating the Safety and Efficacy of BAFFR CAR-T Therapy for Relapsed/Refractory B-cell Malignancies (NCT07345728)Donghua Zhang2026-01-01
Clinical Study on the Safety and Efficacy of CD20/CD19 Cell Injection in the Treatment of Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (NCT07345741)Donghua Zhang2025-12-31
Clinical Study to Evaluate the Safety and Efficacy of γδ T Cells for the Prevention of Relapse After Allogeneic Transplantation in Patients With High-risk Acute Myeloid Leukemia (NCT07237230)Donghua Zhang2025-07-01
Clinical Study of Selinexor-Based Chemotherapy With Minimal or No Cytotoxic Agents in Treatment-Naïve AML Patients Unsuitable for Intensive Therapy: Focusing on Rapid Reduction of Blast Cells (NCT07236931)Donghua Zhang2025-01-01

Track Donghua Zhang automatically

Every clearance here is in the API, with alerts when new ones post.